Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

NCT04987112 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Cancer Metastatic

Interventions

DRUG: CAN1012

Sponsor

CanWell Pharma Inc.